People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroMetrix, Inc. | — | Biotechnology | Series B | $18.7M | $741.4M | 2009 |
W. Mark Lortz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside W. Mark Lortz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David E. Goodman | 1 | 2 |
| Thomas T. Higgins | 1 | 1 |
| Allen J. Hinkle | 1 | 1 |
| Shai N. Gozani | 1 | 1 |
| Timothy R. Surgenor | 1 | 1 |
| Charles R. LaMantia | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.